期刊文献+

外周血HPV DNA检测在宫颈癌复发转移的研究

下载PDF
导出
摘要 人乳头瘤病毒(HPV)感染是引发宫颈癌的主要病因,HPV感染存在病毒血症,HPV DNA可在血中测得。宫颈癌虽较易早期发现和早期诊断,但其复发转移的较早诊断仍很困难。相关研究报道认为,血HPV DNA可反映治疗效果,而宫颈癌治疗后血中HPV DNA的出现能早于影像学等检查手段提示复发转移且特异性较高。随着分子生物学检测技术的进步和发展,外周血HPV DNA有望成为监测宫颈癌早期复发转移的标记物。
出处 《现代妇产科进展》 CSCD 2014年第7期572-573,共2页 Progress in Obstetrics and Gynecology
  • 相关文献

参考文献20

  • 1Sathish N, Abraham P, Peedicayil A, et al. HPVDNA in plas-ma of patients with cervical carcinoma[J]. J Clin Virol,2004, 31(3) :204-209.
  • 2Ho CM, Yang SS, Chien TY , et al. Detection and quantitation of human papillomavirus type 16,18 and 52 DNA in the pe- ripheral blood of cervical cancer patients [ J ]. Gynecol Onto1, 2005,99(3) :615-621.
  • 3Jaberipour M, Samsami A, Sahraiian F, et al. Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with ad- vanced cervical cancer[J]. Asian Pacific J Cancer Prey, 2011.12(1) :163-167.
  • 4王冬冬,林蓓,周丹,张宇华,董伟妍,齐跃,张帆,张淑兰.宫颈癌患者血液中人乳头瘤病毒检出率的临床意义[J].中国医科大学学报,2007,36(3):330-331. 被引量:4
  • 5Chen AC, Keleher A, Kedda MA,et al. Human papillomavirus DNA detected in peripheral blood samples from healthy Aus- tralian male blood donors [ J ]. J Med Virol, 2009,81 ( 10 ) : 1792-1796.
  • 6邵佳,陈曾燕,王洁,马蓉.实时荧光定量PCR检测宫颈癌患者血浆HPV的临床意义[J].中国肿瘤外科杂志,2010,2(5):288-291. 被引量:6
  • 7Yang HJ,Lin VWS,Tsang PCK,et al. Quantification of human papillomavirus DNA in the plasma of patients with cervical eancer[J]. Int J Gynecol Cancer,2004,14(5) :903-910.
  • 8Kay P,Allan B,Dermy L,et al. Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer[ J ]. J Med Viro1,2005 ,75 :435-439.
  • 9王笑石,刘神风.子宫颈癌患者外周血HPV DNA检测的临床意义[J].国际检验医学杂志,2012,33(7):868-869. 被引量:2
  • 10Dona MG,Benevolo M,Pimpinelli F,et al. Comparative eval- uation of different DNA extraction methods for HPV genoty- ping by linear array and INNO-LiPA[J]. J Med Virol,2011, 83(6) :1042-1047.

二级参考文献39

  • 1周瑜琪,吴小华.子宫颈癌患者循环HPV DNA检测及临床意义的研究进展[J].中国癌症杂志,2006,16(2):148-150. 被引量:4
  • 2王冬冬,林蓓,周丹,张宇华,董伟妍,齐跃,张帆,张淑兰.宫颈癌患者血液中人乳头瘤病毒检出率的临床意义[J].中国医科大学学报,2007,36(3):330-331. 被引量:4
  • 3Belinson SE,Belinson JL.Human papillomavirus DNA testing for cervical cancer screening:practical aspects in developing countries[J].Mol Diagn Ther,14(4):215-222.
  • 4Ho CM,Yang SS,Chien TY,et al.Detection and quantitation of human papillomavirus type 16,18 and 52 DNA in the peripheral blood of cervical cancer patients[J].Gynecol Oncol,2005,99(3):615-621.
  • 5Kay P,Allan B,Denny L,et al.Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer[J].J Med Virol,2005,75(3):435-439.
  • 6Yang HJ,Liu VW,Tsang PC,et al.Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer[J].Int J Gynecol Cancer,2004,14(5):903-910.
  • 7Lowy DR,Solomon D,Hildesheim A,et al.Human papillomavirus infection and the primary and secondary prevention of cervical cancer[J].Cancer,2008,113(7 Suppl):1980-1993.
  • 8Vlassov VV,Laktionov PP,Rykova EY.Circulating nucleic acids as a potential source for cancer biomarkers[J].Curr Mol Med,10(2):142-165.
  • 9Lo YM,Chan AT,Chan LY,et al.Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA[J].Cancer Res,2000,60(24):6878-6881.
  • 10Duenas A,Saldivar C,Castillero C,et al.A case of bilateral seminoma in the setting of persistent mullerian duct syndrome[J].Rev Invest Clin,2001,53(2):193-196.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部